Australia: syphilis and chlamydia diagnoses fell after doxyPEP guidance for gay and bisexual men
- A national Australian study tracked STI diagnoses in 78,560 gay and bisexual men from 2022 to 2025.
- After doxyPEP guidance was released, syphilis diagnoses were estimated to be 55% lower than expected.
- Chlamydia diagnoses were estimated to be about 35% lower.
- Gonorrhoea showed no significant change, consistent with doxycycline's weaker effect against it.
Doxycycline post-exposure prophylaxis (doxyPEP) means taking the antibiotic doxycycline after sex to lower the risk of some bacterial sexually transmitted infections (STIs). Australia introduced guidance on its use in late 2023, after years of rising STI rates. A study led by the Burnet Institute and published in Nature Health is the first national-level look at what happened next.
The study
The researchers used data from 29 sexual health and general practice services in the ACCESS surveillance network, covering 78,560 gay and bisexual men aged 16 and over who were tested between January 2022 and December 2025. They compared trends before the guidance (to March 2023) with those after it (October 2023 to December 2025).
Also read: Opt-out screening tripled chlamydia and gonorrhoea testing among teens in US primary care
The results
- Syphilis: diagnoses had been rising by 1.8% a month before the guidance and then fell by 1.3% a month. The researchers estimate 2,430 cases instead of 5,403 without the guidance, a 55% reduction.
- Chlamydia: diagnoses fell by 2.3% a month, an estimated 35% reduction (13,676 instead of 21,280 cases).
- Gonorrhoea: no significant change, which matches earlier evidence that doxyPEP works less well against gonorrhoea.
Limits
Test positivity followed the same pattern, so the fall was unlikely to reflect less testing alone. However, this is an observational study, and the authors note the results may not apply to men who do not attend sexual health services regularly.
Source: Medical Republic
This story is relayed from the source named above; responsibility for its content rests with the original source.
FAQ
What is doxyPEP?
DoxyPEP is doxycycline post-exposure prophylaxis, in which the antibiotic doxycycline is taken after sex to reduce the risk of some bacterial sexually transmitted infections.
How much did syphilis fall in Australia after doxyPEP guidance?
The Australian study estimated that syphilis diagnoses among gay and bisexual men were 55% lower after the doxyPEP guidance than they would otherwise have been.
Did doxyPEP guidance reduce chlamydia in the Australian study?
Yes, the Australian study estimated that chlamydia diagnoses were about 35% lower after the doxyPEP guidance was released.
Does doxyPEP prevent gonorrhoea?
In the Australian study, gonorrhoea diagnoses did not change significantly after doxyPEP guidance, consistent with earlier evidence that doxyPEP is less effective against gonorrhoea.
How many men were included in the Australian doxyPEP study?
The Australian doxyPEP study included 78,560 gay and bisexual men tested at 29 sexual health and general practice services between 2022 and 2025.



